Jyoti Group Enters Pharma Sector

While various industrial units are reported closing down citing security problems, Jyoti Group, one of the major business houses of the country, has started its foray into the pharmaceuticals industry.
Construction works have already started for the factory of Himal Pharma, spread over 20 ropanis of land, in Jharuwarasi VDC of Lalitpur district.
According to Suhrid Jyoti, Executive Director of the new company, the factory is being established with an estimated investment of Rs. 260 million and meeting the WHO GMP standards to produce penicillin as well as non-penicillin medicines in tablets, capsules and syrup as well as ointments. Also in the plan is a unit for injectibles to be added in the near future.
The factory will have a capacity to produce about 82.7 million units of medicines. Initially the factory will produce 80 types of medicines, informed Madhav Pradhan, Chief Executive Officer of the company.
At present, the construction of the compound wall for the factory is completed, while the work is going on with the initial environment impact assessment. The company sources say, the plan is to commission the factory within two years.